NCT07071571

Brief Summary

This study is testing a new device developed to protect the recurrent laryngeal nerve, which is at risk of damage during thyroid and parathyroid surgeries.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
9mo left

Started Aug 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Aug 2025Dec 2026

First Submitted

Initial submission to the registry

July 8, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 17, 2025

Completed
15 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

July 17, 2025

Status Verified

July 1, 2025

Enrollment Period

5 months

First QC Date

July 8, 2025

Last Update Submit

July 16, 2025

Conditions

Thryoid Cancerparathyrıoid Adenoma

Keywords

neuromonitorizationintroperativerecurrent nervenew device

Outcome Measures

Primary Outcomes (1)

  • recurrent nerve identification

    nerve will be identified with new device

    introperatively

Study Arms (1)

thyro,d cases

ACTIVE COMPARATOR
Device: neuromonitoring

Interventions

neuromonitoringDEVICE

new neuromonitorin device will use

thyro,d cases

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-70, diagnosis of benign/malignant thyroid disease, informed consent

You may not qualify if:

  • History of previous nerve injury, concomitant neurological disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

erhan aysan, MD Prof

CONTACT

+902165785000[email protected]

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
no masking
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Recurrent nerve monitoring will be performed in patients with thyroid or parathyroid surgery indications.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof Dr

Study Record Dates

First Submitted

July 8, 2025

First Posted

July 17, 2025

Study Start

August 1, 2025

Primary Completion

January 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 17, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

No need